GT199800165A - Polimorfos de dofetilida. - Google Patents

Polimorfos de dofetilida.

Info

Publication number
GT199800165A
GT199800165A GT199800165A GT199800165A GT199800165A GT 199800165 A GT199800165 A GT 199800165A GT 199800165 A GT199800165 A GT 199800165A GT 199800165 A GT199800165 A GT 199800165A GT 199800165 A GT199800165 A GT 199800165A
Authority
GT
Guatemala
Prior art keywords
polymorphes
dofetilide
invention refers
dophethylide
specifically
Prior art date
Application number
GT199800165A
Other languages
English (en)
Inventor
Ian Colin Appleby
Trevor Jack Newbury
Gary Nichols
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199800165(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of GT199800165A publication Critical patent/GT199800165A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A POLIMORFOS DEL COMPUESTO CONOCIDO COMO DOFETILIDA. MAS CONCRETAMENTE, LA INVENCION SE REFIERE A LOS NUEVOS POLIMORFOS DE DOFETILIDA CONOCIDOS COMO P162, P162A, P143, Y A LOS PROCEDIMIENTOS DE PREPARACION, A LAS COMPOSICIONES QUE LOS CONTIENEN Y A LOS USOS DE TALES POLIMORFOS.
GT199800165A 1997-10-27 1998-10-27 Polimorfos de dofetilida. GT199800165A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (1)

Publication Number Publication Date
GT199800165A true GT199800165A (es) 2000-04-19

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800165A GT199800165A (es) 1997-10-27 1998-10-27 Polimorfos de dofetilida.

Country Status (47)

Country Link
US (1) US6124363A (es)
EP (1) EP1027329B1 (es)
JP (1) JP3569495B2 (es)
KR (1) KR100366167B1 (es)
CN (1) CN1146537C (es)
AP (1) AP906A (es)
AR (1) AR015193A1 (es)
AT (1) ATE232199T1 (es)
AU (1) AU737668B2 (es)
BG (1) BG64125B1 (es)
BR (1) BR9813308A (es)
CA (1) CA2307121C (es)
CO (1) CO4970768A1 (es)
DE (1) DE69811256T2 (es)
DK (1) DK1027329T3 (es)
DZ (1) DZ2632A1 (es)
EA (1) EA002656B1 (es)
ES (1) ES2190620T3 (es)
GB (1) GB9722662D0 (es)
GT (1) GT199800165A (es)
HK (1) HK1033933A1 (es)
HN (1) HN1998000165A (es)
HR (1) HRP20000247B1 (es)
HU (1) HUP0004735A3 (es)
ID (1) ID24658A (es)
IL (1) IL135435A0 (es)
IS (1) IS2179B (es)
MA (1) MA24683A1 (es)
MY (1) MY123352A (es)
NO (1) NO325630B1 (es)
NZ (1) NZ503785A (es)
OA (1) OA11350A (es)
PA (1) PA8462001A1 (es)
PE (1) PE122199A1 (es)
PL (1) PL197379B1 (es)
PT (1) PT1027329E (es)
SA (1) SA98190834B1 (es)
SI (1) SI1027329T1 (es)
SK (1) SK5862000A3 (es)
TN (1) TNSN98193A1 (es)
TR (1) TR200001135T2 (es)
TW (1) TW449589B (es)
UA (1) UA67755C2 (es)
UY (2) UY25222A1 (es)
WO (1) WO1999021829A1 (es)
YU (1) YU24000A (es)
ZA (1) ZA989719B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
AU737668B2 (en) 2001-08-30
NO325630B1 (no) 2008-06-30
DK1027329T3 (da) 2003-02-24
BG64125B1 (bg) 2004-01-30
US6124363A (en) 2000-09-26
TNSN98193A1 (fr) 2005-03-15
WO1999021829A1 (en) 1999-05-06
TR200001135T2 (tr) 2000-09-21
PL340805A1 (en) 2001-02-26
OA11350A (en) 2003-12-17
JP2001521023A (ja) 2001-11-06
HK1033933A1 (en) 2001-10-05
CN1146537C (zh) 2004-04-21
PL197379B1 (pl) 2008-03-31
DE69811256D1 (de) 2003-03-13
CO4970768A1 (es) 2000-11-07
DZ2632A1 (fr) 2003-03-08
SI1027329T1 (en) 2003-04-30
CA2307121C (en) 2006-12-05
AP9801371A0 (en) 1998-12-31
UY25341A1 (es) 1999-09-27
EA002656B1 (ru) 2002-08-29
UY25222A1 (es) 2000-12-29
HUP0004735A2 (hu) 2001-10-28
SK5862000A3 (en) 2001-10-08
PE122199A1 (es) 1999-12-02
HUP0004735A3 (en) 2001-12-28
MA24683A1 (fr) 1999-07-01
BR9813308A (pt) 2000-08-22
PA8462001A1 (es) 2000-05-24
HRP20000247A2 (en) 2000-10-31
HN1998000165A (es) 1999-02-09
ZA989719B (en) 2000-04-26
IS2179B (is) 2006-12-15
EP1027329B1 (en) 2003-02-05
AR015193A1 (es) 2001-04-18
HRP20000247B1 (en) 2002-08-31
KR100366167B1 (ko) 2003-01-09
KR20010031439A (ko) 2001-04-16
NO20002191L (no) 2000-04-27
NO20002191D0 (no) 2000-04-27
GB9722662D0 (en) 1997-12-24
ATE232199T1 (de) 2003-02-15
YU24000A (sh) 2003-02-28
CN1278246A (zh) 2000-12-27
SA98190834B1 (ar) 2006-08-21
IS5426A (is) 2000-03-31
EA200000365A1 (ru) 2000-12-25
BG104373A (en) 2000-12-29
MY123352A (en) 2006-05-31
AU2151299A (en) 1999-05-17
IL135435A0 (en) 2001-05-20
ID24658A (id) 2000-07-27
TW449589B (en) 2001-08-11
UA67755C2 (uk) 2004-07-15
NZ503785A (en) 2004-11-26
JP3569495B2 (ja) 2004-09-22
PT1027329E (pt) 2003-04-30
EP1027329A1 (en) 2000-08-16
CA2307121A1 (en) 1999-05-06
DE69811256T2 (de) 2003-09-18
AP906A (en) 2000-11-30
ES2190620T3 (es) 2003-08-01

Similar Documents

Publication Publication Date Title
HN1999000106A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
GT199900215A (es) Formulaciones agroquimicas.
HN2001000027A (es) Derivados de purina
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
ES2192301T3 (es) Derivados de resorcinol.
SV1997000009A (es) Nuevas oxazolidinonas sustituidas ref. lea 31534-sv
AR011734A1 (es) Analogos del peptido lh-rh, y composiciones farmaceuticas que los contienen
ES2098140T3 (es) Liosferas que contienen gonadotropina.
HN2000000204A (es) Derivados de la purina
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
CU23415B7 (es) Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
GT199800165A (es) Polimorfos de dofetilida.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
HN1999000196A (es) Derivados de indol
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
ES2038641T3 (es) Amidas del acido salicilico, procedimiento para su obtencion y su empleo.
MX9300406A (es) Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen.
EA200100853A1 (ru) Резорциновая композиция
ES2176337T3 (es) Eteres aromaticos derivados de indoles como ligandos "5ht1-like".